Biocon Ltd. NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

392.95 5.20 (1.34%)

35.03% Gain from 52W Low

1.5M

NSE+BSE Volume

NSE 02 Jan, 2026 3:31 PM (IST)

Biocon Ltd. share price target

Biocon Ltd. has an average share price target of 376.40. The consensus estimate represents a downside of -4.21% from the last price of 392.95. View 13 reports from 5 analysts offering long-term price targets for Biocon Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	06 Jan 2026	Biocon	Consensus Share Price Target	392.95	421.70	-	7.32	buy	pdf Detailed Estimates
	12 Feb 2024	Biocon	Axis Direct Target	392.95	285.00	266.70 (47.34%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct The company's capital allocation is on two fronts - R&D and the acquisition of Viatris.This has resulted in returns ratios falling below ~10% despite growth in the business. A huge looming net debt of $1.2 Bn could lead to further stake dilution in Biocon biologics. Recommendation: HOLD pdf Copy Link Share on Share on Share on Share on Alert
	17 Jan 2024	Biocon	Sharekhan Reco Target	392.95	332.00	280.30 (40.19%)	Target met	Buy	pdf post cache		Broker Report Biocon Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	17 Nov 2023	Biocon	Geojit BNP Paribas Target	392.95	260.00	232.75 (68.83%)	Target met	Accumulate	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	13 Nov 2023	Biocon	Axis Direct Target	392.95	250.00	234.80 (67.36%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct We have maintained a Hold on stock. pdf Copy Link Share on Share on Share on Share on Alert
	12 Nov 2023	Biocon	Motilal Oswal Target	392.95	220.00	234.80 (67.36%)		Neutral	pdf post cache		Broker Report Delay in new approvals drags biosimilar prospects Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	16 Aug 2023	Biocon	Geojit BNP Paribas Target	392.95	273.00	257.15 (52.81%)	Target met	Hold	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	14 Aug 2023	Biocon	Axis Direct	392.95	260.00	254.60 (54.34%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Company Outlook & Guidance: Capital allocation on two fronts - R&D and the acquisition of Viatris - has resulted in returns ratios falling below ~10% despite the growth in the business. A huge looming net debt of $1.4 Bn could lead to further stake dilution in Biocon biologics. pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2023	Biocon	ICICI Securities Limited Reco Target	392.95	230.00	256.20 (53.38%)	Target met	Sell	pdf post cache		Broker Report Chasing growth at cost of margins ICICI Securities Limited Biocon’s Q1FY24 performance was dragged by the biologics biz. Profitability of the segment was under pressure owing higher rebates in Fulphila (USD 15mn). Segmental PBT dropped 600bps QoQ to 1.6% in Q1FY24. US market share of Fulphila and Ogivri expanded by 200bps and 100bps QoQ to 16% and 11%, and stable at 12% for bGlargine. pdf Copy Link Share on Share on Share on Share on Alert
	29 May 2023	Biocon	Sharekhan Reco	392.95	266.00	245.20 (60.26%)	Target met	Hold	pdf post cache		Broker Report Biocon Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	ICICI Direct Target	392.95	235.00	239.85 (63.83%)	Target met	Hold	pdf post cache		Broker Report Biocon ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners